MARCH6 Activators belong to a distinctive chemical class characterized by their ability to modulate the activity of Membrane-Associated Ring-CH-type finger 6 (MARCH6), a crucial E3 ubiquitin ligase. The MARCH family of proteins plays a pivotal role in the regulation of various cellular processes, particularly the ubiquitin-proteasome system responsible for targeted protein degradation. MARCH6, specifically, is predominantly associated with the endoplasmic reticulum and participates in the ubiquitination of specific substrates, marking them for degradation by the proteasome. The class of compounds known as MARCH6 Activators exerts their influence by enhancing the catalytic activity of MARCH6, thereby augmenting its ability to attach ubiquitin molecules to target proteins.
Structurally diverse, MARCH6 Activators typically interact with specific domains or binding sites within the MARCH6 protein, eliciting conformational changes that potentiate its enzymatic activity. This activation process leads to an increased ubiquitination of substrates, ultimately influencing cellular homeostasis. The modulation of MARCH6 activity by these activators has garnered attention in the context of cellular quality control mechanisms, as it impacts the degradation of proteins involved in various cellular pathways. The precise molecular mechanisms through which MARCH6 Activators exert their effects remain an active area of research, holding promise for a deeper understanding of cellular regulatory networks and potential implications for targeted interventions in various cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor; indirectly activates the ubiquitin-proteasome system by inhibiting the 26S proteasome. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Inhibitor of MDM2, indirectly activating p53 and potentially influencing ubiquitin-mediated pathways associated with MARCH6. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibitor of NEDD8-activating enzyme, activating the ubiquitin-proteasome system and potentially influencing MARCH6 activation. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
Inhibitor of ubiquitin-activating enzyme E1, potentially activating ubiquitin conjugation pathways associated with MARCH6. | ||||||
PR 619 | 2645-32-1 | sc-476324 sc-476324A sc-476324B | 1 mg 5 mg 25 mg | $77.00 $188.00 $431.00 | 1 | |
Broad-spectrum deubiquitinase (DUB) inhibitor, potentially activating the deubiquitination processes associated with MARCH6. | ||||||
WP1130 | 856243-80-6 | sc-364650 sc-364650A | 10 mg 50 mg | $490.00 $1484.00 | 1 | |
DUB inhibitor that activates deubiquitinating enzymes, potentially influencing ubiquitin-mediated pathways associated with MARCH6. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
HSP90 inhibitor activating the heat shock protein machinery, potentially influencing cellular processes associated with MARCH6 activation. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Derivative of Geldanamycin; inhibits HSP90, potentially activating cellular processes associated with MARCH6. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibitor of Abl kinase potentially activating signaling pathways associated with MARCH6. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor potentially activating signaling pathways associated with protein degradation and MARCH6. | ||||||